On this page
Alternative treatment strategies (ATS) implemented in Massangam Health District (HD) including test and treat with doxycycline and ivermectin mass drug administration (MDA) could only reach 20% of the nomadic population considered to be at higher risk of infection and reservoir for transmission.
As well as the implicit equity concerns with the exclusion of this group from both treatment strategies, there is a risk that they constitute a roaming reservoir of transmission and will impede elimination efforts. A recent qualitative assessment of the ATS in the Massangam health area (HA) revealed the barriers in reaching this hard-to-reach nomadic population.
The barriers included remote, dispersed and small settlements, high mobility, communication barriers, CDD-linked challenges, limited information on them, low awareness of mass drug administration and education/literacy rates.
This study trialled and evaluated a mobile outreach strategy with test and treat with doxycycline, to better serve the semi-nomadic population. In doing so, it explored the movement and turnover of the population and also determined the level (rate) of onchocerciasis infection in them.
Read the summary report (pdf)
Research_Summary_SSI_nomad_FINAL
Read the full report (pdf)
Sightsavers_Nomad report_ FINAL
Other resource
Project: Alternative intervention strategies for accelerating onchocerciasis elimination
Blog: Reaching nomadic communities during COVID-19
‘From the field’ article and video: Finding nomadic communities – our research in action
© 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.
To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.
You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.
These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.
To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.
To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.